Armata Pharmaceuticals, Inc.
ARMP · AMEX
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $67 | $117 | $43 | $132 |
| - Cash | $9 | $14 | $15 | $10 |
| + Debt | $127 | $120 | $49 | $38 |
| Enterprise Value | $184 | $224 | $76 | $160 |
| Revenue | $5 | $5 | $6 | $4 |
| % Growth | 14.2% | -17.8% | 23.1% | – |
| Gross Profit | -$29 | $4 | -$30 | -$16 |
| % Margin | -565.4% | 78.5% | -535.7% | -347.4% |
| EBITDA | -$41 | -$65 | -$36 | -$22 |
| % Margin | -794.6% | -1,445.1% | -654.6% | -490% |
| Net Income | -$19 | -$69 | -$37 | -$23 |
| % Margin | -365.6% | -1,524.5% | -670.2% | -517.5% |
| EPS Diluted | -0.523 | -1.91 | -1.08 | -0.96 |
| % Growth | 72.6% | -76.9% | -12.5% | – |
| Operating Cash Flow | -$38 | -$47 | -$32 | -$24 |
| Capital Expenditures | -$2 | -$8 | -$2 | -$1 |
| Free Cash Flow | -$39 | -$56 | -$35 | -$25 |